Correction: Adjuvant Targeted Treatment of Early Hormone Receptor-positive HER2-negative Breast Cancer: Olaparib, Abemaciclib or Ribociclib - Which One, How and For Whom?
Journal: Geburtshilfe Und Frauenheilkunde
Published:
Abstract
[This corrects the article DOI: 10.1055/a-2562-8469.].
Authors
Stefan Lukac, Kerstin Pfister, Henning Schäffler, Elena Leinert, Angelina Fink, Brigitte Rack, Visnja Fink, Wolfgang Janni, Sabine Heublein
Relevant Conditions